Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: Matched cohort study

Clinical Microbiology and Infection

Volumn 22, Issue 1, 2016, Pages 66-70

  Shofty, B ^a   Neuberger, A ^b,c,d   Naffaa, M E ^d,e   Binawi, T ^d   Babitch, T ^f   Rappaport, Z H ^g,h   Zaaroor, M ^d,i   Sviri, G ^d,i   Paul, M ^b,d  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Division of Infectious Diseases   (Israel)

^c Medicine B   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e Internal Medicine B   (Israel)

^f Medicine E   (Israel)

^g RABIN MEDICAL CENTER   (Israel)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ Department of Neurosurgery ^*  (Israel)

Author keywords

Gram negative; Intrathecal; Intraventricular; Meningitis; Neurosurgery

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; COLISTIN; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CEREBROSPINAL FLUID DRAINAGE; COHORT ANALYSIS; CONTROLLED STUDY; CRANIOTOMY; DRUG TREATMENT FAILURE; FEMALE; GRAM NEGATIVE INFECTION; GRAM NEGATIVE POSTOPERATIVE MENINGITIS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL MORTALITY; SYSTEMIC THERAPY; UNSPECIFIED SIDE EFFECT; URINARY CATHETER; ADVERSE DRUG REACTION; ADVERSE EFFECTS; AGED; GRAM-NEGATIVE BACTERIAL INFECTIONS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; NEUROSURGERY; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MENINGITIS; MIDDLE AGED; NEUROSURGICAL PROCEDURES; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84959537863     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.09.023     Document Type: Article

References (12)

1. Korinek A.M., Baugnon T., Golmard J.L., van Effenterre R., Coriat P., Puybasset L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 2006, 59:126-133. discussion 33.
2. McClelland S., Hall W.A. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 2007, 45:55-59.
3. Korinek A.M. Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidemiologie Hygiene et Prevention. Neurosurgery 1997, 41:1073-1079. discussion 9-81.
4. Sneh-Arbib O., Shiferstein A., Dagan N., Fein S., Telem L., Muchtar E., et al. Surgical site infections following craniotomy focusing on possible post-operative acquisition of infection: prospective cohort study. Eur J Clin Microbiol Infect 2013, 32:1511-1516.
5. Moon C., Kwak Y.G., Kim B.N., Kim E.S., Lee C.S. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother 2013, 19:916-919.
6. Jimenez-Mejias M.E., Pichardo-Guerrero C., Marquez-Rivas F.J., Martin-Lozano D., Prados T., Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002, 21:212-214.
7. Ziaka M., Markantonis S.L., Fousteri M., Zygoulis P., Panidis D., Karvouniaris M., et al. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 2013, 57:1938-1940.
8. Remes F., Tomas R., Jindrak V., Vanis V., Setlik M. Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state. J Neurosurg 2013, 119:1596-1602.
9. Karaiskos I., Galani L., Baziaka F., Katsouda E., Ioannidis I., Andreou A., et al. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents 2013, 41:480-483.
10. Karaiskos I., Galani L., Baziaka F., Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 2013, 41:499-508.
11. Falagas M.E., Bliziotis I.A., Tam V.H. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007, 29:9-25.
12. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.